Logo image of SLBEN.LS

SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) Stock Fundamental Analysis

ELI:SLBEN - Euronext Lisbon - PTSLB0AM0010 - Common Stock - Currency: EUR

3.22  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SLBEN. SLBEN was compared to 46 industry peers in the Entertainment industry. There are concerns on the financial health of SLBEN while its profitability can be described as average. SLBEN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SLBEN had negative earnings in the past year.
SLBEN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SLBEN reported negative net income in multiple years.
In the past 5 years SLBEN always reported negative operating cash flow.
SLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFSLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

SLBEN has a Return On Assets of 6.21%. This is in the better half of the industry: SLBEN outperforms 78.26% of its industry peers.
Looking at the Return On Equity, with a value of 27.11%, SLBEN belongs to the top of the industry, outperforming 89.13% of the companies in the same industry.
SLBEN's Return On Invested Capital of 10.43% is amongst the best of the industry. SLBEN outperforms 80.43% of its industry peers.
Industry RankSector Rank
ROA 6.21%
ROE 27.11%
ROIC 10.43%
ROA(3y)-3.78%
ROA(5y)-1.22%
ROE(3y)-22.24%
ROE(5y)-10.58%
ROIC(3y)N/A
ROIC(5y)N/A
SLBEN.LS Yearly ROA, ROE, ROICSLBEN.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800 1K

1.3 Margins

With an excellent Profit Margin value of 18.66%, SLBEN belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
SLBEN has a Operating Margin of 26.95%. This is amongst the best in the industry. SLBEN outperforms 97.83% of its industry peers.
Looking at the Gross Margin, with a value of 53.73%, SLBEN is in line with its industry, outperforming 52.17% of the companies in the same industry.
In the last couple of years the Gross Margin of SLBEN has declined.
Industry RankSector Rank
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.54%
GM growth 5Y-3.82%
SLBEN.LS Yearly Profit, Operating, Gross MarginsSLBEN.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SLBEN is creating value.
The number of shares outstanding for SLBEN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SLBEN has about the same amount of shares outstanding.
Compared to 1 year ago, SLBEN has a worse debt to assets ratio.
SLBEN.LS Yearly Shares OutstandingSLBEN.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SLBEN.LS Yearly Total Debt VS Total AssetsSLBEN.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

SLBEN has an Altman-Z score of 0.51. This is a bad value and indicates that SLBEN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.51, SLBEN perfoms like the industry average, outperforming 47.83% of the companies in the same industry.
SLBEN has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
SLBEN has a Debt to Equity ratio (1.16) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACC2.02
WACC5.17%
SLBEN.LS Yearly LT Debt VS Equity VS FCFSLBEN.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

SLBEN has a Current Ratio of 0.42. This is a bad value and indicates that SLBEN is not financially healthy enough and could expect problems in meeting its short term obligations.
SLBEN has a Current ratio of 0.42. This is amonst the worse of the industry: SLBEN underperforms 84.78% of its industry peers.
A Quick Ratio of 0.42 indicates that SLBEN may have some problems paying its short term obligations.
SLBEN has a worse Quick ratio (0.42) than 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
SLBEN.LS Yearly Current Assets VS Current LiabilitesSLBEN.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SLBEN have decreased strongly by -844.27% in the last year.
Looking at the last year, SLBEN shows a decrease in Revenue. The Revenue has decreased by -8.56% in the last year.
SLBEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.24% yearly.
EPS 1Y (TTM)-844.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-381.43%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y23.95%
Revenue growth 5Y4.24%
Sales Q2Q%-13.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLBEN.LS Yearly Revenue VS EstimatesSLBEN.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SLBEN.LS Yearly EPS VS EstimatesSLBEN.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SLBEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLBEN.LS Price Earnings VS Forward Price EarningsSLBEN.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLBEN.LS Per share dataSLBEN.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SLBEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPORT LISBOA E BENFICA-FUT S

ELI:SLBEN (3/7/2025, 7:00:00 PM)

3.22

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap74.06M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.85
FCFYN/A
OCF(TTM)-2.52
OCFYN/A
SpS8.29
BVpS5.71
TBVpS-2.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 27.11%
ROCE 14.3%
ROIC 10.43%
ROICexc 10.45%
ROICexgc 20.06%
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
FCFM N/A
ROA(3y)-3.78%
ROA(5y)-1.22%
ROE(3y)-22.24%
ROE(5y)-10.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.54%
GM growth 5Y-3.82%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 52.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 0.51
F-Score4
WACC5.17%
ROIC/WACC2.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)42.64%
Cap/Sales(5y)52.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-844.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-381.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y23.95%
Revenue growth 5Y4.24%
Sales Q2Q%-13.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y965.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.63%
OCF growth 3YN/A
OCF growth 5YN/A